Item Type | Name |
Concept
|
Graft Rejection
|
Academic Article
|
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.
|
Academic Article
|
Liver biopsy interpretation for causes of late liver allograft dysfunction.
|
Academic Article
|
Tacrolimus rescue therapy for renal transplant rejection.
|
Academic Article
|
Effects of donor bone marrow infusion in clinical lung transplantation.
|
Academic Article
|
Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation.
|
Academic Article
|
Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients.
|
Academic Article
|
Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome.
|
Academic Article
|
Non-lymphoid cancer after liver transplantation.
|
Academic Article
|
Immune complex disease in immunosuppressed rat recipients of hamster liver xenografts.
|
Academic Article
|
Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia.
|
Academic Article
|
Use of MHC class I or II "knock out" mice to delineate the role of these molecules in acceptance/rejection of xenografts.
|
Academic Article
|
FK 506 versus cyclosporine in pediatric liver transplantation.
|
Academic Article
|
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report.
|
Academic Article
|
Analysis of T lymphocytes infiltrating human hepatic allografts.
|
Academic Article
|
Management of intestinal transplantation in humans.
|
Academic Article
|
Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors.
|
Academic Article
|
Immunopathology of antibodies as effectors of orthotopic liver allograft rejection.
|
Academic Article
|
Strategy of FK 506 therapy in liver transplant patients: effect of graft function.
|
Academic Article
|
Cadaveric small bowel and small bowel-liver transplantation in humans.
|
Academic Article
|
A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejection.
|
Academic Article
|
Second-set rejection of mouse liver allografts is dependent on radiation-sensitive nonparenchymal cells of graft bone marrow origin.
|
Academic Article
|
Phenytoin decreases the blood concentrations of sirolimus in a liver transplant recipient: a case report.
|
Academic Article
|
Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression.
|
Academic Article
|
Tacrolimus rescue therapy for renal allograft rejection--five-year experience.
|
Academic Article
|
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial.
|
Academic Article
|
The dichotomous functions of passenger leukocytes in solid-organ transplantation.
|
Academic Article
|
Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation.
|
Academic Article
|
Donor species complement after liver xenotransplantation. The mechanism of protection from hyperacute rejection.
|
Academic Article
|
Intestinal transplantation in composite visceral grafts or alone.
|
Academic Article
|
State of immunosuppressive agents in organ transplantation.
|
Academic Article
|
Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts.
|
Academic Article
|
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus.
|
Academic Article
|
FK 506 used as rescue therapy for human liver allograft recipients.
|
Academic Article
|
Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.
|
Academic Article
|
The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation.
|
Academic Article
|
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath.
|
Academic Article
|
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts.
|
Academic Article
|
Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation.
|
Academic Article
|
Weaning of immunosuppression in liver transplant recipients.
|
Academic Article
|
A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results.
|
Academic Article
|
Clinical small bowel or small bowel plus liver transplantation under FK 506.
|
Academic Article
|
[Clinical experience with FK 506].
|
Academic Article
|
Infusion of donor leukocytes to induce tolerance in organ allograft recipients.
|
Academic Article
|
Preservation injury and acute rejection of rat intestinal grafts: protection afforded by pyruvate.
|
Academic Article
|
Fine-needle aspiration biopsy in pancreatic transplantation.
|
Academic Article
|
Real-time monitoring of acute liver-allograft rejection using the Banff schema.
|
Academic Article
|
Allogeneic orthotopic liver transplantation in mice: a preliminary study of rejection across well-defined MHC barriers.
|
Academic Article
|
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients.
|
Academic Article
|
Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection.
|
Academic Article
|
Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging.
|
Academic Article
|
Effect of donor age and sex on the outcome of liver transplantation.
|
Academic Article
|
Prevention of sensitization and hyperacute rejection in liver and heart xenografts by FK 506 plus donor antigens.
|
Academic Article
|
Central venulitis in the allograft liver: a clinicopathologic study.
|
Academic Article
|
Donor bone marrow infusion in liver recipients: effect on the occurrence of acute cellular rejection.
|
Academic Article
|
A randomized trial of inhaled cyclosporine in lung-transplant recipients.
|
Academic Article
|
Clinical intestinal transplantation in 1998: Pittsburgh experience.
|
Academic Article
|
Renal function after conversion from cyclosporine to FK 506 in liver transplant patients.
|
Academic Article
|
Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model.
|
Academic Article
|
Intraindividual and interindividual variations in the pharmacokinetics of mycophenolic acid in liver transplant patients.
|
Academic Article
|
Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts.
|
Academic Article
|
Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression.
|
Academic Article
|
Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem.
|
Academic Article
|
Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation.
|
Academic Article
|
The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival.
|
Academic Article
|
Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection.
|
Academic Article
|
Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up.
|
Academic Article
|
Enteric-drained pancreas transplants monitored by fine-needle aspiration biopsy.
|
Academic Article
|
FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts.
|
Academic Article
|
Complement and target cells belong to the same species after liver xenografting: protection from hyperacute rejection.
|
Academic Article
|
"Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression.
|
Academic Article
|
Rapamycin: friend, foe, or misunderstood?
|
Academic Article
|
Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice.
|
Academic Article
|
The long-term efficacy of multivisceral transplantation.
|
Academic Article
|
Five-year experience with tacrolimus rescue for renal allograft rejection.
|
Academic Article
|
Apoptosis of graft-infiltrating cytotoxic T cells: a mechanism underlying "split tolerance" in mouse liver transplantation.
|
Academic Article
|
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression.
|
Academic Article
|
Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years.
|
Academic Article
|
Caroli's disease and orthotopic liver transplantation.
|
Academic Article
|
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection.
|
Academic Article
|
Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants.
|
Academic Article
|
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.
|
Academic Article
|
Lymphocytes of bronchoalveolar lavages from heart-lung transplant recipients.
|
Academic Article
|
Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide.
|
Academic Article
|
Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant.
|
Academic Article
|
Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts.
|
Academic Article
|
An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
|
Academic Article
|
Intestinal transplantation: a coming of age.
|
Academic Article
|
Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model.
|
Academic Article
|
Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
|
Academic Article
|
The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
|
Academic Article
|
Reversal of acute cellular rejection after renal transplantation with Campath-1H.
|
Academic Article
|
The effect of thymus transplantation on allograft rejection in thymectomized bone marrow chimeras.
|
Academic Article
|
Serum protein immunogenicity: implications for liver xenografting.
|
Academic Article
|
Liver allograft rejection: an overview of morphologic findings.
|
Academic Article
|
Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations.
|
Academic Article
|
Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
|
Academic Article
|
Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption.
|
Academic Article
|
Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients.
|
Academic Article
|
The antigenicity of serum proteins and their role in xenograft rejection.
|
Academic Article
|
Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report.
|
Academic Article
|
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
|
Academic Article
|
Interleukin-2 and interleukin-12 mediate distinct effector mechanisms of liver allograft rejection.
|
Academic Article
|
Cardiac operations in solid-organ transplant recipients.
|
Academic Article
|
Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial.
|
Academic Article
|
Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation.
|
Academic Article
|
Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts.
|
Academic Article
|
Role of MHC class I and CD8(+) T cells in the pathogenesis of chronic rejection.
|
Academic Article
|
Neutralization of IL-12 reverses rejection of mouse liver allografts from Flt3-ligand-treated donors and is associated with suppression of both cellular and humoral responses.
|
Academic Article
|
Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations.
|
Academic Article
|
Prolonged survival of heart allografts transduced with AAV-CTLA4Ig.
|
Academic Article
|
Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipients.
|
Academic Article
|
Cotransplantation with myeloid-derived suppressor cells protects cell transplants: a crucial role of inducible nitric oxide synthase.
|
Academic Article
|
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study.
|
Academic Article
|
Impact of Orthoclone OKT3 on liver transplantation.
|
Academic Article
|
The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us?
|
Academic Article
|
Clinical intestinal transplantation: new perspectives and immunologic considerations.
|
Academic Article
|
Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection.
|
Academic Article
|
Mechanisms of protection from humoral rejection by a xenografted liver.
|
Academic Article
|
Future prospects in immunosuppression for liver transplantation.
|
Academic Article
|
Blockade of the CD28/B7 and CD40/CD40L costimulatory pathways does not ameliorate chronic rejection in a mouse aortic allograft model of direct antigen presentation.
|
Academic Article
|
Randomised trialomania? The multicentre liver transplant trials of tacrolimus.
|
Academic Article
|
A prospective randomized trial of FK506-based immunosuppression after renal transplantation.
|
Academic Article
|
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.
|
Academic Article
|
Rejection triggers liver transplant tolerance: Involvement of mesenchyme-mediated immune control mechanisms in mice.
|
Academic Article
|
Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease.
|
Academic Article
|
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles.
|
Academic Article
|
Pregnancy after liver transplantation under tacrolimus.
|
Academic Article
|
Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up.
|
Academic Article
|
Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs.
|
Academic Article
|
Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells.
|
Academic Article
|
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats.
|
Academic Article
|
Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance.
|
Academic Article
|
Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization.
|
Academic Article
|
Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance.
|
Academic Article
|
Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report.
|
Academic Article
|
Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance.
|
Academic Article
|
Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
|
Academic Article
|
Outcome of liver transplantation using donors 60 to 79 years of age.
|
Academic Article
|
Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?
|
Academic Article
|
Preservation solutions in liver transplantation: what are the options?
|
Academic Article
|
Current status of intestinal transplantation in children.
|
Academic Article
|
OKT3 in the reversal of acute hepatic allograft rejection.
|
Academic Article
|
Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation.
|
Academic Article
|
The protection from humoral rejection given by a liver xenograft is species-specific and non-MHC restricted.
|
Academic Article
|
Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus.
|
Academic Article
|
Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet.
|
Academic Article
|
Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity.
|
Academic Article
|
Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
|
Academic Article
|
Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
|
Academic Article
|
Pediatric renal transplantation under tacrolimus-based immunosuppression.
|
Academic Article
|
A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up.
|
Academic Article
|
Cytidine potentiates the inhibitory effect of brequinar sodium on concordant cardiac xenograft rejection.
|
Academic Article
|
Sequential infiltration of class I and class II specific alloreactive T cells in human cardiac allografts.
|
Academic Article
|
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients.
|
Academic Article
|
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies.
|
Academic Article
|
Histologic monitoring of human small bowel allografts with clinical correlation.
|
Academic Article
|
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes.
|
Academic Article
|
Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumour rejection.
|
Academic Article
|
Simultaneous pancreas-kidney transplantation at the University of Pittsburgh.
|
Academic Article
|
Attenuation of aortic graft arteriosclerosis by systemic administration of Allotrap peptide RDP58.
|
Academic Article
|
Tacrolimus for rescue of refractory renal allograft rejection.
|
Academic Article
|
Adjuvant bone marrow infusion in clinical organ transplant recipients.
|
Academic Article
|
Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis.
|
Academic Article
|
Immunosuppression: evolution in practice and trends, 1994-2004.
|
Academic Article
|
A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.
|
Academic Article
|
A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report.
|
Academic Article
|
Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events.
|
Academic Article
|
Understanding and preventing late graft loss.
|
Academic Article
|
Present state of immunosuppressive therapy in liver transplant recipients.
|
Academic Article
|
Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature.
|
Academic Article
|
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.
|
Academic Article
|
Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.
|
Academic Article
|
Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor.
|
Academic Article
|
Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506.
|
Academic Article
|
Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody.
|
Academic Article
|
Weaning of immunosuppression in long-term liver transplant recipients.
|
Academic Article
|
Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients.
|
Academic Article
|
Stromal cell-based immunotherapy in transplantation.
|
Academic Article
|
Immunological factors influencing liver graft survival.
|
Academic Article
|
Functional studies of in vivo committed lymphocytes propagated from organ transplants.
|
Academic Article
|
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report.
|
Academic Article
|
Long-term results of pancreas transplantation under tacrolius immunosuppression.
|
Academic Article
|
Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions.
|
Academic Article
|
Effect of OKT3 on survival and rate of retransplantation.
|
Academic Article
|
Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus.
|
Academic Article
|
Murine liver allograft transplantation: tolerance and donor cell chimerism.
|
Academic Article
|
Predicting immunosuppressant dosing in the early postoperative period with noninvasive indocyanine green elimination following orthotopic liver transplantation.
|
Academic Article
|
Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil.
|
Academic Article
|
Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors.
|
Academic Article
|
Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy.
|
Academic Article
|
An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis.
|
Academic Article
|
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.
|
Academic Article
|
Near-total human face transplantation for a severely disfigured patient in the USA.
|
Academic Article
|
Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection.
|
Academic Article
|
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
|
Academic Article
|
Hamster-to-rat liver xenografts protect extrahepatic organs from rejection.
|
Academic Article
|
Liver transplantation in patients with HIV infection.
|
Academic Article
|
Human hepatic stellate cells inhibit T-cell response through B7-H1 pathway.
|
Academic Article
|
Nelfinavir, a protease inhibitor, increases sirolimus levels in a liver transplantation patient: a case report.
|
Academic Article
|
Renal transplantation in recipients over the age of 60: the impact of donor age.
|
Academic Article
|
Liver, kidney, and thoracic organ transplantation under FK 506.
|
Academic Article
|
Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization.
|
Academic Article
|
Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation.
|
Academic Article
|
Pathologic observations in human allograft recipients treated with FK 506.
|
Academic Article
|
The immunolymphatic theory of chronic rejection.
|
Academic Article
|
The antibody crossmatch in liver transplantation.
|
Academic Article
|
Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
|
Academic Article
|
Almost total absence of chronic rejection in primary pediatric liver transplantation under tacrolimus.
|
Academic Article
|
High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation.
|
Academic Article
|
Intrahepatic human islet transplantation at the University of Pittsburgh: results in 25 consecutive cases.
|
Academic Article
|
C-C Chemokine Receptor Type 2-Dependent Migration of Myeloid-Derived Suppressor Cells in Protection of Islet Transplants.
|
Academic Article
|
Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation.
|
Academic Article
|
Limitations of current liver transplant immunosuppressive regimens: renal considerations.
|
Academic Article
|
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.
|
Academic Article
|
Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence from an International Randomized Trial of Everolimus-Based Immunosuppression.
|
Academic Article
|
Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review.
|
Academic Article
|
Myeloid-derived suppressor cells increase and inhibit donor-reactive T cell responses to graft intestinal epithelium in intestinal transplant patients.
|
Academic Article
|
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.
|
Academic Article
|
Induction Therapy With Antithymocyte Globulin and Delayed Calcineurin Inhibitor Initiation for Renal Protection in Liver Transplantation: A Multicenter Randomized Controlled Phase II-B Trial.
|